Management of Dyspnea in Advanced Cancer
Publication Date: January 31, 2021
Last Updated: March 14, 2022
Recommendations
Screening and assessment
1.1. Clinicians should perform systematic assessment of dyspnea at every inpatient and outpatient encounter in patients with advanced cancer using validated patient-reported outcome measures.
6539
1.2. For patients who are unable to self-report, clinicians should use a validated observation measure.
6539
1.3. Whenever possible, patients with dyspnea should undergo a comprehensive evaluation for the severity, chronicity, potential causes, triggers, and associated symptoms, as well as emotional and functional impact.
6539
Title
Management of Dyspnea in Advanced Cancer
Authoring Organization
American Society of Clinical Oncology